help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Limas, C.
Right arrow Articles by Limas, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Limas, C.
Right arrow Articles by Limas, C. J.

American Journal of Pathology, Vol 117, 360-371, Copyright © 1984 by American Society for Investigative Pathology


REGULAR ARTICLES

Comparative effects of hydralazine and captopril on the cardiovascular changes in spontaneously hypertensive rats

C Limas, B Westrum and CJ Limas

Vascular changes that develop during the course of blood pressure rise in spontaneously hypertensive rats (SHRs) can be modified by antihypertensive therapy. It is not known, however, whether there is selectivity in the structural response to specific antihypertensive drugs. This issue was examined by comparing the effects of a direct vasodilator (hydralazine) and a converting enzyme inhibitor (captopril) on morphologic aspects of the cardiovascular system. Male SHRs, 21 weeks of age, were given either hydralazine (HCl plus hydrochlorothiazide, captopril plus hydrochlorothiazide, or hydrochlorothiazide alone. Untreated age-matched SHRs and Wistar-Kyoto normotensive rats (WKYs) were used as controls. Animals were sacrificed at 27-28 weeks of age. Both hydralazine and captopril lowered significantly the blood pressure of SHRs, whereas hydrochlorothiazide alone was ineffective. The heart/body weight ratios were dramatically reduced in captopril-treated SHRs to below the level of WKYs; hydralazine induced only a very modest (5%) reduction, whereas the diuretic alone was ineffective. The morphology of the aortic intima improved dramatically in response to captopril and hydralazine and, to a lesser extent, hydrochlorothiazide alone. This effect becomes apparent within 6 weeks of treatment, and the only evidence of preexisting disease is the persistence of collagen in the subendothelium. Captopril and hydralazine, but not hydrochlorothiazide alone, reduce the thickness of the aortic media below that of normotensive controls. In addition, captopril and hydralazine improve the structure of small intrarenal vessels. There was a strong correlation between the relative effectiveness of the three pharmacologic agents in lowering blood pressure and in improving the changes of intrarenal vessels. These results highlight the capacity of antihypertensive therapy to arrest or reverse the structural sequelae of hypertension. In addition, they underscore the heterogeneity in the response of different components of the cardiovascular system, which, in part, reflects selectivity in the action of antihypertensive agents.


This article has been cited by other articles:


Home page
HypertensionHome page
C. Smallegange, T. M. Hale, T. L. Bushfield, and M. A. Adams
Persistent Lowering of Pressure by Transplanting Kidneys From Adult Spontaneously Hypertensive Rats Treated With Brief Antihypertensive Therapy
Hypertension, July 1, 2004; 44(1): 89 - 94.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. M Pinto, M. Paul, and D. Ganten
Lessons from rat models of hypertension: from Goldblatt to genetic engineering
Cardiovasc Res, July 1, 1998; 39(1): 77 - 88.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Ichikawa, H. Suzuki, K. Kumagai, H. Kumagai, M. Ryuzaki, M. Nishizawa, and T. Saruta
Differential Modulation of Baroreceptor Sensitivity by Long-term Antihypertensive Treatment
Hypertension, September 1, 1995; 26(3): 425 - 431.
[Abstract] [Full Text]


Home page
CirculationHome page
F. G. Spinale, H. H. Holzgrefe, R. Mukherjee, R. B. Hird, J. D. Walker, A. Arnim-Barker, J. R. Powell, and W. H. Koster
Angiotensin-Converting Enzyme Inhibition and the Progression of Congestive Cardiomyopathy : Effects on Left Ventricular and Myocyte Structure and Function
Circulation, August 1, 1995; 92(3): 562 - 578.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American Society for Investigative Pathology.